<DOC>
	<DOC>NCT01697644</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to assess and compare the efficacy and safety of two dose levels of somatropin over a long period (till final height is reached). This trial is an extension to trials GHRETARD/BDP/14/NL (a 2-year initial trial) and GHRETARD/BPD/20/NL (a 2-year extension trial).</brief_summary>
	<brief_title>Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation</brief_title>
	<detailed_description />
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Completion of the GHRETARD/BPD/20/NL trial Written informed consent from child and/or parents/guardians before continuation in the extension trial</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>